Medrio is a software company based in the United States, specializing in healthcare software and electronic data capture (EDC) solutions. Founded in 2005, the company has developed a platform that supports clinical studies by enabling efficient data collection and management. Medrio's EDC technology has been utilized by organizations such as Paragonix Technologies for their GUARDIAN-HEART clinical study, which examines the effects of controlled hypothermic preservation in heart transplantation. The platform is noted for its ease of use, allowing clinical teams to set up study infrastructures rapidly and make mid-study changes without third-party support. Medrio's solutions are designed to empower lean research teams by providing them with the autonomy to configure studies according to their specific needs, thereby enhancing trial efficiencies. The company's focus on user-friendly interfaces and robust technical support has facilitated quick onboarding and effective management of complex clinical data across multiple sites and registries. With a workforce of 201 to 500 employees, Medrio continues to contribute to advancements in clinical research through its innovative software solutions.